Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
(NYSE: CLDI) Delayed: 1.27 -0.09 (6.62%)
Previous Close $1.36    52 Week High
Open $1.32    52 Week Low
Day High $1.34    P/E N/A 
Day Low $1.25    EPS
Volume 135,777